Medicine and Dentistry
Radiation Therapy
100%
Malignant Neoplasm
53%
Soft Tissue Sarcoma
32%
Connective Tissue Cancer
31%
Diseases
29%
Recurrent Disease
28%
Neoplasm
26%
Overall Survival
20%
Melanoma
19%
Disease Specific Survival
13%
American Indian
13%
Hazard Ratio
12%
Neck
12%
Medicare
11%
Metastatic Carcinoma
9%
Local Therapy
9%
Survival Rate
9%
Patient Care
9%
Preoperative Radiotherapy
9%
Metastatic Melanoma
9%
Surgery
8%
Hypofractionated Radiotherapy
8%
Clinical Trial
7%
Cancer Screening
7%
Surveillance, Epidemiology, and End Results
7%
Osteosarcoma
7%
Angiosarcoma
7%
Cancer Therapy
7%
Systemic Therapy
6%
Intensity Modulated Radiation Therapy
6%
Immunotherapy
6%
Retroperitoneal Sarcoma
6%
Multimodality Cancer Therapy
6%
Cancer
6%
Malignant Peripheral Nerve Sheath Tumor
6%
Breast Cancer
6%
Surgical Margin
5%
Dedifferentiated Liposarcoma
5%
Desmoid Tumor
5%
Neurofibromatosis Type I
5%
Distant Metastasis Free Survival
5%
Keyphrases
Radiation Therapy
51%
Local Control
26%
Soft Tissue Sarcoma
24%
Disease-specific Survival
13%
Local Recurrence
13%
Surgery Therapy
12%
Hazard Ratio
12%
Radiotherapy
12%
Overall Survival
11%
Sarcoma
11%
Confidence Interval
10%
Combined Modality Therapy
10%
Head-and-neck
10%
Intraoperative Radiation Therapy
9%
Local Therapy
9%
Distant Metastasis
8%
Adjuvant Radiation Therapy
8%
Neoadjuvant
8%
Trunk
7%
Undifferentiated Pleomorphic Sarcoma
7%
Chemotherapy
7%
Single Institution
6%
Hypofractionated Radiation Therapy
6%
Melanoma
6%
Metastatic Melanoma
6%
Tumor
6%
Immune Checkpoint Inhibitors
6%
Soft Tissue
6%
Extraskeletal Osteosarcoma
5%
Desmoid Tumor
5%
Cancer Clinical Trials
5%
Multivariable
5%
Surveillance Epidemiology
5%
Postoperative Radiotherapy
5%
Cancer Patients
5%
Dedifferentiated Liposarcoma (DDLPS)
5%